Eyal Attar
Chief Tech/Sci/R&D Officer en VOR BIOPHARMA INC. .
Fortuna: 264 853 $ al 31/03/2024
Cargos activos de Eyal Attar
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| VOR BIOPHARMA INC. | Chief Tech/Sci/R&D Officer | 12/10/2022 | - |
Historial de carrera de Eyal Attar
Antiguos cargos conocidos de Eyal Attar.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/01/2014 | 01/01/2019 |
| Harvard Medical School | Corporate Officer/Principal | - | - |
| APREA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/04/2019 | - |
Formación de Eyal Attar.
| UNC School of Medicine | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 6 |
Operativa
| Chief Tech/Sci/R&D Officer | 3 |
| Doctorate Degree | 1 |
| Corporate Officer/Principal | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| AGIOS PHARMACEUTICALS, INC. | Health Technology |
| VOR BIOPHARMA INC. | Health Technology |
| APREA THERAPEUTICS, INC. | Health Technology |
- Bolsa de valores
- Insiders
- Eyal Attar
- Experiencia
